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Objective: This study attempted to com-
pare two models for selective (people at
elevated risk) and indicated (those with
subsyndromal depressive symptoms) pre-
vention and to determine the optimal
strategy for prevention of late-life depres-
sion.
Method: Onset was assessed at 3 years
with the Geriatric Mental State AGECAT in
a randomly selected cohort of 1,940 non-
depressed and nondemented older peo-
ple in Amsterdam. Risk factors that can
easily be identified in primary care were
used.
Results: The association of risk factors
with depression incidence was expressed
in absolute and relative risk estimates,
number needed to treat, and population-
attributable fractions. Prevention models
were identified with classification and re-
gression tree analyses. In the indicated
prevention model, subsyndromal symp-
toms of depression were associated with
a risk of almost 40% of developing de-
pression and a number needed to treat of
5.8, accounting for 24.6% of new cases.
Adding more risk factors raised the abso-
lute risk to 49.3%, with a lower number
needed to treat but also lower attribut-
able fraction values. In the selective pre-
vention model, spousal death showed the
highest risk, becoming even higher if the
subjects also had a chronic illness. Over-
all, the attributable fraction values in the
indicated model were higher, identifying
more people at risk.
Conclusions: Consideration of the costs
and benefits of both models in the con-
text of the availability of evidence-based
preventative interventions indicated that
prevention aimed at elderly people with
depressive symptoms is preferred. The fo-
cus on treatment should be readdressed;
a new approach is needed, with a stron-
ger emphasis on prevention.
(Am J Psychiatry 2006; 163:1611–1621)
The adverse consequences of depression are well es-
tablished. Currently, of all illnesses, depressive disorder
causes the largest amount of nonfatal burden, accounting
for almost 12% of all years lived with disability worldwide
(1). Depression is also associated with excess morbidity
and mortality (2), higher demands on caregivers and
higher service use, and has substantial economical impli-
cations (3). In community-dwelling elderly people, the
prevalence of depression requiring clinical attention is
13.5% (4), and more than 50% have a chronic course (5, 6).
Although effective treatment is available, case finding and
adequate treatment in primary care are generally poor (7,
8). Still, even if all patients with depression were optimally
treated with evidence-based interventions, only 34% of
the disease burden in terms of years lived with disability
could be averted (9). From the public health perspective,
it is therefore of great interest to consider the possibility
of depression prevention (10, 11). However, evidence-
based preventive strategies aimed at reducing the inci-
dence of late life depression in community living elderly
people are sparse.
In prevention, different strategies can be chosen ac-
cording to the stages or transitions in the development of
a disorder (12) (Figure 1). Universal prevention aims to in-
fluence the behavior of the whole population to prevent
the onset of disease. Examples of universal prevention are
programs informing the population about the risk of alco-
hol intake or the benefits of physical exercise. Selective
prevention is aimed at people who are at risk because they
have been exposed to certain risk factors. In the case of de-
pression, risk indicators are, for example, spousal loss and
physical illness (13). The third form, indicated prevention,
targets people who already have early or subsyndromal
symptoms, in whom an intervention may reduce the like-
lihood of developing a full-blown case of depression (12,
14). An example of indicated prevention is cognitive ther-
apy for the prevention of psychosis in people at ultrahigh
risk (15, 16) or pharmacotherapy for people with mild cog-
nitive impairment to delay the onset of Alzheimer’s dis-
ease (17).
The choice for a specific type of prevention depends on
the “untreated” prognosis of the disorder, in combination
with the costs, benefits, and possible adverse conse-
quences of different types of intervention. An ethical di-
lemma is that identifying a healthy person as a possible fu-
ture case and starting some kind of intervention could
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carry certain negative consequences and should only be
applied if the alternative has a significantly higher proba-
bility of adverse consequences. In the case of depression,
evidence-based universal prevention of depression is cur-
rently nonexistent. Selective prevention may focus on
people with certain risk indicators, such as exposure to
loss. Indicated prevention would be directed at persons
with depressive symptoms below the diagnostic threshold
for “clinically relevant depression” (18, 19). For both ethi-
cal reasons and reasons of cost-effectiveness, preventative
measures aimed at reducing the incidence of depression
should target subjects with high a priori risk through ex-
posure to multiple risk factors (20). Furthermore, for prac-
tical reasons, persons at risk should be easily identifiable
in primary care, and risk profiles have to be simple and
unambiguous. From a public health perspective, preven-
tion should be cost-effective and lead to a substantial re-
duction of total disease burden. This implies that the se-
lected risk indicators should be indicative of a substantial
proportion of new cases.
The current study explores selective and indicated pre-
vention models to identify high-risk groups among older
geriatric patients, bearing in mind the above-mentioned
qualifications. It seeks to identify combinations of expo-
sures that predict the largest health gains in the most cost-
effective way when prevention is successful in blocking
the adverse effects of these risk factors. These risk factors
could then be used in primary care as an easy-to-use
checklist or screener to identify patients at elevated risk of
becoming a future case of depressive disorder. For indi-
cated prevention, the use of a screening instrument to de-
tect subsyndromal depression would be required. Because
this is more time-consuming than recognizing subjects on
the basis of more straightforward risk factors needed for
selective prevention, the benefits of both approaches are
compared. The study is based on data from the Amster-
dam Study of the Elderly, a large and prospective cohort
study of depression in community-living elderly people
incorporating a comprehensive set of risk factors associ-
ated with late-life depression (13, 21).
Method
Sampling and Nonresponse
The Amsterdam Study of the Elderly is a prospective cohort
study on the incidence of depression in a large and representative
sample of noninstitutionalized older persons (65+). Informed
consent was asked and obtained from each participant before
they began the study. The study was approved by the Medical Eth-
ics Committee of the Vrije Universiteit Amsterdam. The popula-
tion base for Amsterdam Study of the Elderly included all nonin-
stitutionalized individuals in the 65–84-year age bracket who
lived in the city of Amsterdam and were registered with a general
practitioner at baseline. The study was actively supported by the
general practitioners, whose lists were used as the sampling
frame. In the Netherlands, general practitioners are the gatekeep-
ers of the health care system, and almost every citizen is on the
list of a general practitioner. In this role, general practitioners in
the Netherlands generally provide social support and have a long-
standing personal relationship with their patients. Thus, the
source population consisted of almost all of the noninstitutional-
ized population. The sample was drawn from a list of 30 general
practices spread throughout the city; practices were selected from
all of those registered within the city of Amsterdam, 22 randomly
and eight by convenience from a network of general practitioners
participating in medical research. The profile of the general prac-
tice population over age 65 in terms of age and gender, corre-
sponds to the noninstitutionalized population in Amsterdam (22,
23). Within each practice, respondents were randomly selected
from four age strata spanning 5 years each (65–69 and 80–84). In
order to obtain equally sized age strata at follow-up, the older old
were oversampled. Out of a total sample of 5,666, 4,051 (71.5%)
responded and formed the baseline sample. Interviews with these
subjects were conducted between May 1990 and November 1991.
The profile of the general practice population over age 65 in terms
of age and gender corresponds to the noninstitutionalized Am-
sterdam population.
FIGURE 1. Types of Prevention and Treatment According to
Transitions in Depression Development
Healthy
Universal
prevention
Vulnerable
Selective
prevention
Prodrome
Indicated
prevention
Handicap
model
Recovery
Relapse
prevention
Disorder
TreatmentDisease
management
Chronicity
FIGURE 2. Amsterdam Study of the Elderly
Source population
(N=5,666)
Study sample
(N=4,051)
3-year
follow-up
(N=2,244)
Died, was 
institutionalized,
or left Amsterdam
(N=258)
Refused
to participate
(N=1,357)
Died
(N=656)
Unwilling
to participate
(N=662)
Too ill or
cognitively
impaired
(N=282)
Not available
for other reasons
(N=207)
Am J Psychiatry 163:9, September 2006 1613
SCHOEVERS, SMIT, DEEG, ET AL.
ajp.psychiatryonline.org
At follow-up 3 years later (median=38 months), 2,244 (55.4%)
were reinterviewed, 656 (16.2%) people were deceased, 662
(16.3%) refused to cooperate further, 282 (7.0%) were too ill or
cognitively impaired to respond, and 207 (5.1%) were not avail-
able for interview because of a variety of other reasons. For this
study, 523 subjects with depression (12.9%) or 261 with dementia
(6.4%) at baseline were excluded. The study cohort consisted of
all 1,940 respondents at follow-up who were neither depressed
nor demented at baseline for whom complete data were available
at follow-up (Figure 2).
Measures
A 1-hour interview was developed to gather information on
psychiatric symptoms, demographic and medical status, per-
sonal history of depression, and family history. The interview
consisted of the Dutch translation of the Mini-Mental State Ex-
amination (24); all Geriatric Mental State examination items re-
lated to organic, affective, and anxiety syndromes (25, 26); the Ac-
tivities of Daily Living scale (27); the Instrumental Activities of
Daily Living scale (28); and part of the CAMDEX interview (29).
The interview was administered during home visits by lay inter-
viewers who were trained to use video sessions and regularly su-
pervised. The same Geriatric Mental State AGECAT package with
an identical algorithm was used in the second wave of the study.
When reinterviewing subjects, the raters were unaware of previ-
ous data and diagnoses.
Psychiatric Diagnoses
Diagnoses of dementia, depression and generalized anxiety
disorder were made according to the Geriatric Mental State AGE-
CAT system. Diagnostic levels 3–5 correspond reliably to cases of
depression requiring clinical attention in both the community
(30) and in elderly hospital patients (31). Geriatric Mental State
AGECAT has proven reliability in epidemiological studies, as be-
came evident through replication studies (26). Geriatric Mental
State AGECAT generates both a nonhierarchical syndrome level
and a more narrowly defined diagnostic level. The diagnostic case
level is calculated from the syndrome level with hierarchy from
organic to depression to anxiety disorder. To be able to also assess
overlapping comorbidity influences, syndrome levels were used
in the analyses because otherwise the diagnostic hierarchy would
bias the results. Depression “caseness” at baseline and follow-up
was defined as a Geriatric Mental State AGECAT level 3 or higher
(26). Subjects not depressed at baseline who had become de-
pressed at follow-up were considered to be incident cases. Sub-
jects with depression case levels 1 or 2 at baseline were classified
as having “subsyndromal depression.”
FIGURE 3. Indicated Prevention Model
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Risk Indicators
Sociodemographic variables included age, gender, and educa-
tional level, the latter of which was dichotomized into lower (pri-
mary school or less) and higher (more than primary school) edu-
cation. Living situation was assessed with the associated
questions in the Geriatric Mental State AGECAT. A personal history
of depression was ascertained by a relevant CAMDEX question.
The question was considered affirmative if treatment had pre-
viously been requested. The presence of chronic diseases was as-
sessed with the pertinent CAMDEX questions on myocardial inf-
arction, stroke, cancer, lung disease, diabetes, Parkinson’s
disease, arthritis, and epilepsy. Cognitive status was assessed by
MMSE score. Cognitive impairment was defined as an MMSE
score below 24. Sleeping disorder was determined by two ques-
tions from the Geriatric Mental State on “trouble falling asleep”
(yes or “I would have problems if I did not use sleeping medica-
tion”) and “early wakening” (at least two times per week at least 2
hours earlier than usual). Disability was measured with a com-
bined scale consisting of all activities of daily living and Instru-
mental Activities of Daily Living items (32, 33). Subjects were con-
sidered disabled if the total score was two or more points below
the maximum. This indicates that subjects were “in need of help”
to perform at least two of the tasks mentioned or were “unable to
perform’” at least one task.
Data Analysis
The analyses were conducted in several steps. First, standard
epidemiological techniques were used to calculate the absolute
and relative risk of becoming a case for subjects with or without
being exposed to a certain risk indicator.
TABLE 1. Demographic and Clinical Characteristics of a Randomly Selected Cohort of 1,940 Nondepressed and Nonde-
mented Older People and Associations With Follow-Up
Variable
Time 0 Time 1
N % N % for Time 0
N 4,051 2,244 55.4
Age (years)
65–69 836 20.6 544 65.1
70–74 974 24.0 581 59.7
75–79 1,050 25.9 581 55.3
80–86 1,191 29.4 538 45.2
Sex
Male 1,523 37.6 817 53.6
Female 2,528 62.4 1,427 56.4
Education
Higher than primary school 2,335 57.6 1,394 59.7
Primary school or less 1,716 42.4 850 49.5
Socioeconomic status
High 182 4.5 121 66.5
Middle 1,803 44.7 1,045 58.0
Low 2,050 50.8 1,075 52.4
Living situation
With other(s) 2,197 54.2 1,201 54.6
Alone 1,854 45.8 1,043 56.3
Social support
No/little 3,209 79.2 1,841 57.4
Help from others 842 20.8 403 47.9
Chronic diseases
None 1,894 46.8 1,128 59.6
One or more 2,157 53.2 1,116 51.7
Psychiatric history
None 3,449 85.1 1,909 55.3
Yes 602 14.9 335 55.6
Disability
Able 2,931 72.4 1,759 60.0
Disabled 1,020 27.6 485 43.3
Mini-Mental State Examination score
0–21 3,281 81.0 1,969 60.0
26–30 522 12.9 209 40.0
22–25 248 6.1 66 26.6
Organic syndrome level
None 3,790 93.6 2,173 57.3
Case 261 6.4 71 27.2
Sleep disturbance
No 2,615 64.6 1,467 56.1
Yes 1,436 35.4 77 54.1
Generalized anxiety disorder
None 3,923 96.8 2,180 55.6
Case 128 3.2 64 50.0
Depression
None 2,667 65.8 1,534 57.5
Subsyndromal 861 21.3 462 53.6
Case level 523 12.9 248 47.4
*p<0.05. **p<0.01. ***p<0.001. 
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In a second step, the importance of risk indicators for the onset
of disorder at population level was quantified by taking into ac-
count the level of exposure to a risk factor in the population, also
called the exposure rate, and the population-attributable fraction.
The attributable fraction indicates by how many percentage
points the incidence rate of depression in the population are low-
ered when the adverse effect of the risk factor (or combination of
risk factors) can be completely blocked. Similarly, a measure of the
efficiency of a preventive intervention can be calculated: the num-
ber needed to be treated (34). The number needed to treat can be
interpreted as a measure of efficiency, showing how many people
must be protected from the adverse influence of a risk factor to
avoid one new case of depression. Because the number needed to
treat values presented here are based on the assumption that an
intervention is able to completely block the adverse influence of a
risk factor on the onset of depression, these should be adapted de-
pending on the actual efficacy of each preventative intervention. If
an intervention has 50% efficacy in containing the effect of a risk
factor, the actual number needed to treat should thus be multi-
plied by 2. Using Stata (35) statistics such as relative risk, attribut-
able fraction and the number needed to treat were obtained in a
multivariate context with control for competing risks (10).
In the third step, the relative risk, attributable fraction, the
number needed to treat and E statistics were used to find the best
values for efficiency (i.e., low needed to treat values) and the best
values for health gains (i.e., highest attributable fraction values)
for combinations of exposures. Targeting preventative interven-
tions on groups that have been exposed to specific combinations
of risk factors may yield higher health gains (relative risk, attribut-
able) against less effort (number needed to treat).
To trace the effect of multiple exposures in all their combina-
tions, we used a method known as classification and regression
tree analysis (36, 37) and adapted it for our purposes. Classifica-
tion and regression tree analysis can graphically be represented
as tree-like figures (Figure 3). First, a parent node is selected that
optimizes the number needed to treat, the relative risk, and at-
tributable fraction values in preferably the smallest exposure rate
groups. This parent node branches off in two directions, creating
child nodes in which people are not only exposed to the risk fac-
tor in the parent node but also to an additional risk factor in the
child node. Therefore, the first generation of child nodes captures
the effect of double exposures, the second generation of child
nodes represents the effect of triple exposures, and so on. At each
node, both branches (for subjects with and subjects without that
specific risk indicator) are followed up to determine the number
needed to treat, the relative risk, and the attributable fraction val-
ues of combined exposures. Thus, the sample is split into smaller
subgroups at each step. To determine the optimal child nodes for
our purpose, the following hierarchy of decision rules was used:
1. Child node with the lowest number needed to treat (i.e., the
greatest efficiency)
2. Child node with the highest attributable fraction (i.e., great-
est health gain)
3. When ties occurred, the child node was selected with the
smallest exposure (E) rate because targeting smaller groups
is logistically and economically less demanding when the
number needed to treat and the attributable fraction values
are equal.
The following rules were employed for the termination of
branches:
1. Relative risk <1.00 or relative risk not significant (i.e., no risk
involved)
2. Attributable fraction <5% or attributable fraction not signif-
icant (i.e., no health gain)
3. Number needed to treat >50 or number needed to treat not
significant (i.e., not efficient)
Results
Sample Characteristics and Response Pattern
The baseline sample characteristics are shown in Table
1 and have been described in more detail elsewhere (13).
In multivariate logistic regression analysis, nonresponse
at the follow-up assessment was predicted by higher age,
male gender, lower education, living alone, chronic dis-
ease(s), disability, organic caseness, and depression (di-
chotomized as depression case level versus no depression
case level). When subjects who died between measure-
Response Versus 
Nonresponse
Response Versus Nonresponse 
Excluding Deceased Subjects
χ2 df χ2 df
89.20*** 3 17.20*** 3
3.02 1 6.80** 1
41.40*** 4 29.20*** 1
21.10** 2 11.90** 2
1.03 1 1.22 1
24.40*** 1 4.40* 1
24.90*** 1 0.40 1
0.02 1 1.60 2
91.60*** 1 10.50** 1
161.30*** 2 84.80*** 2
89.70*** 1 35.50*** 5
1.49 1 2.48 1
1.56 1 4.10* 1
19.40*** 2 10.48** 2
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ments were excluded from these analyses, only lower edu-
cation, living alone and baseline organic syndrome pre-
dicted nonresponse. At follow-up, 309 subjects (15.9% of
the study sample) had become depressed. The following
analyses investigate the associations of risk factors with
incident depression.
Predictors of Late-Life Depression
Table 2 shows the predictor model and the associations
with the onset of depression, with 95% confidence inter-
vals. Statistically significant associations between risk indi-
cators and depression incidence were found for the follow-
ing risk factors: medical illness, disability, a personal
history of depression, recent loss of spouse, sleep distur-
bance, generalized anxiety disorder, and subsyndromal de-
pression. From these, the absolute risk of developing de-
pression when exposed to a risk factor was calculated. The
number needed to treat values for the risk factors in the
model ranged from 242 (living alone, 95% CI not statisti-
cally significant) to 4.1 (95% CI=2.3–19.6) for subjects with
generalized anxiety disorder. For each risk factor, the asso-
ciated attributable fraction was also calculated, ranging
from 24.6 (subsyndromal depression, 95% CI=18.8−30.0) to
1.1 (living alone, 95% CI not statistically significant).
Indicated Prevention Model (classification and 
regression tree analysis)
Following the aforementioned algorithm, subsyndro-
mal depression clearly was the preferred primary node
(Figure 3). Although the number need to treat of 5.8 was
higher than that of generalized anxiety disorder (4.1) (Ta-
ble 2), the associated attributable fraction of depression
was far greater (24.6%) and that of generalized anxiety dis-
order (2.0%) was below the threshold of 5% for the termi-
nation of branches. The prevention model was then con-
tinued for each branch, starting with subjects who had
and those who did not have subsyndromal depressive
symptoms. In subjects with subsyndromal depression, the
next branching candidate was having a disability. This
step reduced the number needed to treat to 3.9, but it also
limited the attributable fraction to 9.7%. The model was
then further subdivided with living alone and female sex
as following risk indicators. Because the attributable frac-
tion was below 5% at the next step (all→subsyndromal
symptoms→disability→living alone→female sex→), the
branch was terminated here. In subjects with subsyndro-
mal depression who were not disabled, having a chronic
illness (absolute risk=30.9%, number needed to treat=6.0)
and living alone (absolute risk=32.9%, number needed to
treat=5.6, attributable fraction=4.9%) were chosen as sub-
sequent child nodes. In subjects who did not have depres-
sive symptoms, spousal death was the strongest predictor,
with an absolute risk of 31.4% of developing depression, a
number needed to treat of 6.1, and an attributable fraction
of 5.4%. Further branching was not performed because
the attributable fraction became too small (<5%).
The way in which the number needed to treat, the attri-
bution fraction, and exposure rate are interrelated is
graphically illustrated in Figure 4. It shows how adding
more risk factors to the model results in a higher absolute
risk, a lower number needed to treat, but also a lower at-
tributable fraction.
Selective Prevention Model (classification and 
regression tree analysis)
Figure 5 shows the model without subsyndromal symp-
toms of depression. Now the focus is on selective preven-
tion and easy case recognition by general practitioners.
Following the algorithm described above, the first branch-
ing candidate on the basis of number needed to treat and
attributable fraction scores is spousal death, with a num-
ber needed to treat of 5.3 and an attributable fraction of
8.2%. This was chosen as the primary (or parent) node.
The selective-prevention model then yielded medical ill-
ness as the next branching candidate in subjects who lost
their spouses. This step reduced the number needed to
treat to 3.7 but also limited the attributable fraction to
5.8%. Because of this, further branching was not per-
formed. In subjects who did not recently lose their part-
ner, being disabled was the most important risk indicator,
with a number needed to treat of 11.5 and an attributable
fraction of 9.0%. Further risk indicators were the presence
TABLE 2. Prediction Model for Late-Life Depression in Primary Care: Bivariate Associations With Depression Onseta
Risk Factors
Exposure 
Rate (%) 95% CI Relative Risk 95% CI
Absolute Risk of 
Developing Depression 
Given Exposure (%)
Female sex 60.5 58.3–62.6 1.20 0.97–1.49 17.1
Education (primary school or less) 35.6 33.4–37.7 1.12 0.91–1.39 17.1
Living alone 44.0 41.8–46.2 1.03 0.84–1.26 16.2
Medical illness 47.8 45.6–50.1 1.46 1.19–1.80* 19.1
Disability 17.7 16.0–19.4 1.74 1.39–2.17* 24.5
Mini-Mental State Examination score <24 2.6 1.9–3.3 1.13 0.62–2.07 18.0
Personal history of depression or anxiety 13.0 11.5–14.5 1.61 1.25–2.06* 23.7
Spousal loss 6.9 5.8–8.0 2.29* 1.77–2.99 33.6
Trouble sleeping 30.4 28.3–32.4 1.73* 1.41–2.12 22.6
Generalized anxiety disorder 1.3 0.8–1.8 2.56* 1.57–4.19 40.0
Subsyndromal depression 22.7 20.9–24.6 2.43* 1.99–2.97 29.3
a Subjects without depression and/or dementia at baseline (N=1,940).
*p<0.05.
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of a chronic medical illness and female gender. The latter
step reduced the attributable fraction but only slightly af-
fected the number needed to treat (from 8.6 to 8.3).
Discussion
In this study, high-risk groups for incident depression
were identified in a large cohort of elderly patients seen by
general practitioners. Because case finding is generally
poor, and both the prevalence and persistence of late-life
depression are of major concern, the goal was to identify
groups in primary care with a high vulnerability for de-
pression according to easily identifiable criteria. Preven-
tion is of interest, bearing in mind that even optimal care
can only reduce the burden of depression by 34% (9). Be-
cause the detection of subsyndromal depressive symp-
toms requires more effort than recognizing other, more
easily identifiable risk indicators in primary care, two
models were compared that either incorporated or ex-
cluded subsyndromal depression as a predictor of the fu-
ture onset of a full-blown depressive disorder. Thus, the
potential health benefits of preventative measures aimed
at reducing the incidence of late-life depression could be
determined, taking into account the time that should be
invested in adequate case finding in primary care. Al-
though this approach, combining clinical, epidemiologi-
cal, and public health perspectives has been strongly ad-
vocated (14), it is relatively new to the field of common
mental disorders.
Our findings suggest that indicated prevention that in-
volves identifying subsyndromal depressive symptoms as
the most important risk indicator is the preferred option
for identifying groups at high risk of developing depres-
sion. Subjects with depressive symptoms had a risk of al-
most 30% and accounted for 24.6% of the new cases at fol-
low-up. With a number needed to treat of 5.8, which
carries the promise of efficient interventions in this group,
these subjects are of major interest for preventative inter-
ventions. Further subdivision of the sample according to
combinations of risk factors yielded groups with an even
higher risk of developing depression and lower numbers
needed to treat, but these more narrowly focused ap-
proaches have a smaller impact on the incidence rate of
depression in the population. For example, disabled
women with subsyndromal symptoms who live alone had
a 47% risk of becoming depressed, a number needed to
treat of only 3.2 but a relatively low attributable fraction
(5.9%), indicating that the incidence rate would only fall
by 5.9% at best.
In a recent meta-analysis on short-term psychothera-
peutic interventions aimed at people with subsyndromal
depressive symptoms, these were found to reduce the in-
cidence of depression by 30% (38). If this were applied to a
sample such as ours, the number needed to treat for inter-
vention would be 19.3 (5.8/0.3) for those with subsyndro-
mal depression. For a relatively intensive form of treat-
ment, this may be considered to be too great an effort, and
it could be argued that one should start with those sub-
jects who have the highest vulnerability. Further subdivi-
sion in the classification and regression tree analysis then
95% CI
Number Needed 
to Treat 95% CI
Attributable 
Fraction (%) 95% CI
14.9–19.2 35.2 16.4–∞ 10.8 –1.4  to 21.5
14.3–19.9 54.9 18.9–∞ 4.1 –3.2 to 10.8
13.7–18.6 242 27.0–∞ 1.1 –7.5 to 9.1
16.5–21.6 16.6* 10.8–36.2 18.1* 8.7 to 26.6
19.9–29.0 9.6* 6.6–18.0 11.5* 6.7 to 16.2
7.3–28.7 47.0 7.8–∞ 0.3 –1.3 to 1.9
18.5–29.0 11.2* 6.9–29.0 7.3* 3.3 to 11.2*
25.6–41.6 5.3* 3.7–9.3 8.2*  5.2 to 11.1
19.2–26.0 10.5* 7.5–17.5 18.2* 11.5 to 24.4
20.8–59.2 4.1* 2.3–19.6 2.0* 0.8 to 3.2
25.0–33.5 5.8* 4.6–7.9 24.6* 18.8 to 30.0
FIGURE 4. Consequences of Adding Risk Factors to the Pre-
diction Model in Terms of Absolute Risk, Number Needed
to Be Treated, and Attributable Fraction
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leads to smaller subgroups that were exposed to more risk
factors. In women with disability who live alone, the ad-
justed number needed to treat would be 10.7 (3.2/0.3). As
an alternative to cognitive behavior therapy, less costly
forms of indicated prevention should also be taken into
consideration. Both bibliotherapy (39) and the Coping
With Depression course, a manualized form of self-help
with instructions on mood management, were found to be
effective therapies for unipolar depression, with effect
sizes that are comparable to those of other treatment mo-
dalities for depression (40). Very recently, minimal contact
psychotherapy along these lines has been proven effective
in reducing the onset of depression in primary care pa-
tients with subthreshold depression (41). Also in low-cost
computerized form, such interventions have proved effec-
tive (42, 43).
If one considers selective prevention of late-life depres-
sion, our analyses show that, in line with earlier findings
(44), elderly persons who recently lost their spouses are at
great risk of developing depression, and even more if they
also have a chronic medical condition (absolute risk=
41.8%, number needed to treat=3.7). Overall, the attribut-
able fractions in this model were somewhat smaller, which
means that fewer cases can be prevented. Examples of
preventative programs directed at persons who lost their
spouses include self-help groups of fellow sufferers that
convene for emotional exchange and support, specific
courses on competences needed to cope with single life,
and “widow-to-widow” programs in which women who
had lost their husbands earlier visit recently widowed
women for emotional and practical support. Although
these programs have shown promising results in terms of
postbereavement adaptation (45) and social functioning
(46), the evidence of efficacy in reducing depression onset
is limited. In a meta-analysis of eight types of such inter-
ventions, Cuijpers et al. (47) found an effect size of 0.34 in
relation to control subjects, but the number of published
studies is still limited, and this difference was not statisti-
cally significant. When we consider the fact that these are
low-cost community-based interventions, randomized
controlled trials are urgently needed.
Indicated prevention thus has the best chance of detect-
ing large groups of subjects at high risk of developing de-
pression, with numbers needed to treat that could make
preventative actions cost-effective by using available evi-
dence-based interventions. Still, in comparison with se-
lective prevention, indicated prevention requires the extra
effort of screening subjects for subsyndromal depression.
FIGURE 5. Selective Prevention Model
Absolute risk=27.0%;
number needed to treat=8.3;
attributable fraction=5.8%
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A number of screening instruments have been validated
for case finding in community living elderly. These include
the Center for Epidemologic Studies Depression Scale, a
30-item questionnaire on depressive symptoms (4, 48, 49)
but more recently also the 15-item version of the Geriatric
Depression Scale (50–53) has demonstrated its effective-
ness for detecting elderly subjects with depressive symp-
toms in the community. The screening of large numbers of
patients in primary care has been shown to be both feasi-
ble and effective (54, 55). Therefore, primary care facilities
appear to be well equipped to find elderly persons with
subsyndromal symptoms.
Strengths and Limitations
The Amsterdam Study of the Elderly is a large prospec-
tive cohort study with long follow-up intervals, and it in-
corporated a wide range of risk factors for late-life depres-
sion measured independently of depression onset. The
findings are representative for urban populations of com-
munity dwelling older persons, and are highly relevant for
primary care.
Nonetheless, a number of limitations deserve mention-
ing. First of all, studies with a limited number of measure-
ments tend to overrepresent chronic forms of disorder.
Between assessments, subjects may have had both onset
and remission of shorter episodes of depression. At the
same time, it may be concluded that even with a 3-year in-
terval, the set of risk factors employed in this study can
identify a large number of future cases of depression. Sec-
ond, although the risk factors cover many domains rele-
vant to depression, biological (genetic) risk indicators are
less well represented in the data set. Other factors that
would ideally have been available are medication use,
substance abuse or dependence, and specific medical
conditions, such as thyroid disorders that may be associ-
ated with depression onset. Third, it should be concluded
that this study does not prove that preventative interven-
tions are successful in community-living elderly. Available
studies on indicated prevention were mostly performed in
younger adults. However, because other forms of treat-
ment of depression are also effective in the elderly, there
would be no reason to doubt the efficacy of preventative
interventions in elderly subjects. When considering the
potential benefits of prevention, there is an urgent need
for randomized, controlled trials to address this matter.
Conclusions
The results of this study stress the importance of pre-
ventative action for depression as the primary common
mental disorder. And to answer the question put forward
in the title of this article, “Yes, we do know where to begin.”
Indicated prevention of depression is the preferred strat-
egy. Still, because this involves screening patients for sub-
clinical depression, selective prevention of depression
may prove to be a good alternative. It will require only the
use of a simple checklist of the relevant risk factors, and
the expected health gains can also be substantial. Either
way, primary care facilities are equipped to perform ade-
quate case finding. Nonetheless, even though minimal
contact, low-cost, evidence-based interventions for peo-
ple with subsyndromal symptoms are available, their cost-
effectiveness has to be established in proper randomized
trials. Recent data, however, indicate that this may be the
case (11, 41). Therefore, it is time to reconsider whether
the exclusive focus on the treatment of common mental
disorders should be adapted and whether an allocation of
personnel and resources for prevention may be more ef-
fective in reducing both individual suffering and the over-
all costs of health care.
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